Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.502EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.285EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.582EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.580EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.306EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used